Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma (Q27851797)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma |
scientific article |
Statements
5 June 2012
0 references
106
0 references
12
0 references
1997-2003
0 references
1 reference
1 reference
1 reference
1 reference
1 reference